NasdaqGS - Nasdaq Real Time Price USD
DexCom, Inc. (DXCM)
69.88 +0.96 (+1.39%)
As of 1:30:36 PM EDT. Market Open.
Trade DexCom on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreChart Range Bar
Loading chart for DXCM
- Previous Close
68.92 - Open
69.00 - Bid 65.24 x 200
- Ask 75.64 x 200
- Day's Range
68.92 - 71.08 - 52 Week Range
54.11 - 89.98 - Volume
1,766,042 - Avg. Volume
5,533,069 - Market Cap (intraday)
26.965B - Beta (5Y Monthly) 1.44
- PE Ratio (TTM)
29.99 - EPS (TTM)
2.33 - Earnings Date (est.) Jul 29, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
85.21
Recent News
View More
Performance Overview
Trailing total returns as of 6/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
DXCM
5.29%
S&P 500 (^GSPC)
7.41%
1-Year Return
DXCM
20.20%
S&P 500 (^GSPC)
20.69%
3-Year Return
DXCM
44.87%
S&P 500 (^GSPC)
69.09%
5-Year Return
DXCM
34.23%
S&P 500 (^GSPC)
72.34%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 6/23/2026
Market Cap
26.59B
Enterprise Value
25.56B
Trailing P/E
29.58
Forward P/E
26.95
PEG Ratio (5yr expected)
1.29
Price/Sales (ttm)
5.75
Price/Book (mrq)
8.99
Enterprise Value/Revenue
5.31
Enterprise Value/EBITDA
17.28
Financial Highlights
Profitability and Income Statement
Profit Margin
19.31%
Return on Assets (ttm)
9.65%
Return on Equity (ttm)
35.62%
Revenue (ttm)
4.82B
Net Income Avi to Common (ttm)
930.4M
Diluted EPS (ttm)
2.33
Balance Sheet and Cash Flow
Total Cash (mrq)
2.42B
Total Debt/Equity (mrq)
46.83%
Levered Free Cash Flow (ttm)
1.06B
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View MoreRaising target price to $23.00
TRUPANION INC has an Investment Rating of HOLD; a target price of $23.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of High; and a Value Subrating of Low.
RatingPrice TargetWhat does Argus have to say about TRUP?
TRUPANION INC has an Investment Rating of HOLD; a target price of $21.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of High; and a Value Subrating of Low.
RatingPrice TargetWhat does Argus have to say about TRUP?
TRUPANION INC has an Investment Rating of HOLD; a target price of $21.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of High; and a Value Subrating of Low.
RatingPrice TargetDexCom Earnings: Slower Growth and Higher Input Costs Could Weigh on 2026
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
RatingPrice Target